Comparison of SARS-CoV (2003) and SARS-CoV-2 (2019)
- 10.2991/978-2-494069-31-2_8How to use a DOI?
- SARS; SARS-CoV-2; coronavirus; pandemic
This article compares the most well-known outbreaks of coronaviruses in the past twenty years, SARS-CoV and SARS-CoV-2, to illustrate the correlation between them and impact on human society. Pre-existing scholarship has been consulted to compare and analyze the viruses’ known range of symptoms, incubation period, risk factors, fatality rate, and sequelae. The main difference in SARS and SARS-CoV-2’s symptoms is that more than half of SARS-CoV-2’s transmissions are asymptomatic, which is rare for SARS-CoV. Most clinical features for both diseases appeared similar to the symptoms of basic respiratory diseases. SARS-CoV-2 shows a longer incubation period in general. Risk factors for both diseases include age, with elders being more susceptible. SARS has a higher case fatality rate than SARS-CoV-2. The long-term sequelae of both diseases are still uncertain, however, after recovery, overall lung functions are damaged. As technology have progressed, there are more varieties of vaccine being developed for SARS-CoV-2 than SARS.
- © 2022 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Tingyi Cui PY - 2022 DA - 2022/12/29 TI - Comparison of SARS-CoV (2003) and SARS-CoV-2 (2019) BT - Proceedings of the 2022 6th International Seminar on Education, Management and Social Sciences (ISEMSS 2022) PB - Atlantis Press SP - 59 EP - 65 SN - 2352-5398 UR - https://doi.org/10.2991/978-2-494069-31-2_8 DO - 10.2991/978-2-494069-31-2_8 ID - Cui2022 ER -